MyFinsight
Home
Blog
About
Contact
Download
Download image
Total comprehensive
loss
-$74,394K
(13.15%↑ Y/Y)
Interest income
$8,745K
(-26.51%↓ Y/Y)
Other income, net
$3,361K
(-19.26%↓ Y/Y)
Net loss
-$74,283K
(14.24%↑ Y/Y)
Total other
comprehensive gain (loss)
-$111K
(-111.55%↓ Y/Y)
Total other income,
net
$12,106K
(-24.63%↓ Y/Y)
Loss from operations
-$86,389K
(15.87%↑ Y/Y)
Unrealized gains (losses)
on marketable...
-$111K
(-111.55%↓ Y/Y)
Collaboration revenue
$30,909K
(36.75%↑ Y/Y)
Total operating
expenses
$117,298K
(-6.38%↓ Y/Y)
Gain on lease
modification
$1,632K
Research and development
$85,466K
(-9.59%↓ Y/Y)
General and
administrative
$27,550K
(-2.85%↓ Y/Y)
Impairment of long-lived
assets
$5,914K
(146.62%↑ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
Foghorn Therapeutics Inc. (FHTX)
Foghorn Therapeutics Inc. (FHTX)